FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Scot Remick

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Panayiotis Savvides; Jay K Wasman; John J Wright; Robert Chapman; Afshin Dowlati; Pingfu Fu; Pierre Lavertu; Govardhanan Nagaiah; Scot C Remick
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid.
Matthew M Cooney; Joseph Bokar; Robert Dreicer; Joseph Gibbons; Smitha Krishnamurthi; Anne Ness; Charles Nock; Scot C Remick; Mary Beth Rodal; Afshin Dowlati
Phase I trial of pomalidomide given for patients with advanced solid tumors.
Abhijeet Bhanegaonkar; Rahul Khanna; S Suresh Madhavan; Scot C Remick
Declining mammography screening in a state Medicaid Fee-for-Service program: 1999-2008.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Scot Remick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Panayiotis Savvides; Jay K Wasman; John J Wright; Robert Chapman; Afshin Dowlati; Pingfu Fu; Pierre Lavertu; Govardhanan Nagaiah; Scot C Remick
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid.
Thyroid : official journal of the American Thyroid Association 2013;23(5):600-4.
2012: Matthew M Cooney; Joseph Bokar; Robert Dreicer; Joseph Gibbons; Smitha Krishnamurthi; Anne Ness; Charles Nock; Scot C Remick; Mary Beth Rodal; Afshin Dowlati
Phase I trial of pomalidomide given for patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2012;70(5):755-61.
2012: Abhijeet Bhanegaonkar; Rahul Khanna; S Suresh Madhavan; Scot C Remick
Declining mammography screening in a state Medicaid Fee-for-Service program: 1999-2008.
Journal of women's health (2002) 2012;21(8):821-9.
2012: Narin Apisarnthanarax; Sean Carlson; Derek V Chan; Pingfu Fu; Stanton L Gerson; Anita Gilliam; Lili Liu; Scot C Remick; Seth R Stevens; Sarolta K Szabo; Gary S Wood; Kevin D Cooper
Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.
Archives of dermatology 2012;148(5):613-20.
2012: Richard M Steingart; George L Bakris; Helen X Chen; Ming-Hui Chen; Thomas Force; S Percy Ivy; Carl V Leier; Daniel Lenihan; JoAnn Lindenfeld; Glenn Liu; Michael L Maitland; Scot C Remick; W H Wilson Tang
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
American heart journal 2012;163(2):156-63.
2012: Yi Guo; Michael D Mueller; William Petros; Eddie Reed; Scot C Remick; Pingfu Fu; Honglan Zhu; Jing Jie Yu
Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer.
Oncology reports 2012;27(1):286-92.
2011: Ticiana B Leal; Heinz-Josef Lenz; Patricia M LoRusso; Sridhar Mani; James Mier; Angela Davies; Merrill J Egorin; Anne Hamilton; S Percy Ivy; Rachel Neuwirth; Ramesh K Ramanathan; Scot C Remick; John Sarantopoulos; Stephen Shibata; Chris H Takimoto; Karthik Venkatakrishnan; Lisa von Moltke; John J Wright; Daniel Mulkerin
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Cancer chemotherapy and pharmacology 2011;68(6):1439-47.
2011: Alejandro D Ricart; Kale E Ruby; John Sarantopoulos; Anthony W Tolcher; Angela Zambito; Edward A Ashton; Joanna M Brell; Matthew M Cooney; Maria A Feldman; Kazuko Matsuda; Gerardo Medina; Mark S Munsey; Scot C Remick
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2011;68(4):959-70.
2011: Akm Hossain; Percy Ivy; Jonathan Kaltman; Daniel J Lenihan; Alice Chen; Wendy Taddei-Peters; Scot C Remick
The importance of clinical grading of heart failure and other cardiac toxicities during chemotherapy: updating the common terminology criteria for clinical trial reporting.
Heart failure clinics 2011;7(3):373-84.
2011: Shamsuddin Virani; Lola Burke; Scot C Remick; Jame Abraham
Barriers to recruitment of rural patients in cancer clinical trials.
Journal of oncology practice / American Society of Clinical Oncology 2011;7(3):172-7.
2011: Rahul Khanna; S Suresh Madhavan; Abhijeet Bhanegaonkar; Scot C Remick
Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program.
Journal of women's health (2002) 2011;20(5):739-47.
2011: Charles J Nock; Joanna M Brell; Joseph A Bokar; Matthew M Cooney; Brenda Cooper; Joseph Gibbons; Smitha Krishnamurthi; Sudhir Manda; Panayiotis Savvides; Scot C Remick; Percy Ivy; Afshin Dowlati
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
Investigational new drugs 2011;29(1):126-30.
2011: Timothy James Kinsella; Xiaolin Li; Nancy L Oleinick; Elma D Baron; Valdir Colussi; Kevin D Cooper; Charles L Hoppel; Stephen T Ingalls; Malcolm E Kenney; Seth R Stevens; Scot C Remick
Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.
Frontiers in oncology 2011;1():14.
2011: Mehdi Hamadani; Michael D Craig; Laura F Gibson; Scot C Remick
The evolving role of statins in hematopoietic stem and progenitor cell transplantation.
American journal of blood research 2011;1(1):57-64.
2011: Govardhanan Nagaiah; James Parmentier; Akm Hossain; Colin J Mooney; Scot C Remick
Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment.
Journal of oncology 2011;2011():542358.
2011: Joseph Putila; Scot C Remick; Nancy Lan Guo
Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based study.
PloS one 2011;6(2):e17493.
2010: Govardhanan Nagaiah; Christy Stotler; Jackson Orem; Walter O Mwanda; Scot C Remick
Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa.
Current opinion in oncology 2010;22(5):437-42.
2010: Govardhanan Nagaiah; Scot C Remick
Combretastatin A4 phosphate: a novel vascular disrupting agent.
Future oncology (London, England) 2010;6(8):1219-28.
2010: Christopher J Sweeney; Chris Takimoto; Leslie Wood; Jennifer M Porter; William G Tracewell; Mona Darwish; Denise M D'Andrea; Scot C Remick
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
Cancer chemotherapy and pharmacology 2010;66(2):345-56.
2010: Michael L Maitland; George L Bakris; Henry R Black; Helen X Chen; Jean-Bernard Durand; William J Elliott; S Percy Ivy; Carl V Leier; Joann Lindenfeld; Glenn Liu; Scot C Remick; Richard M Steingart; W H Wilson Tang
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Journal of the National Cancer Institute 2010;102(9):596-604.
2010: Joseph A Sparano; Jeannette Y Lee; Lawrence D Kaplan; Alexandra M Levine; Juan Carlos Ramos; Richard F Ambinder; William Wachsman; David Aboulafia; Ariela Noy; David H Henry; Jamie Von Roenn; Bruce J Dezube; Scot C Remick; Manisha H Shah; Lawrence Leichman; Lee Ratner; Ethel Cesarman; Amy Chadburn; Ronald Mitsuyasu
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
Blood 2010;115(15):3008-16.
2010: Ramesh K Ramanathan; Merrill J Egorin; Charles Erlichman; Scot C Remick; Suresh S Ramalingam; Cynthia Naret; Julianne L Holleran; Cynthia J Teneyck; S Percy Ivy; Chandra P Belani
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(9):1520-6.
2010: Jing Jie Yu; Pingfu Fu; John J Pink; Dawn Dawson; Jay Wasman; Jackson Orem; Walter O Mwanda; Honglan Zhu; Xiaobing Liang; Yi Guo; William P Petros; Ronald T Mitsuyasu; Henry Wabinga; Scot C Remick
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma.
PloS one 2010;5(5):e10477.
2009: Shyam Bhakta; Susan M Flick; Matthey M Cooney; John Frank Greskovich; Robert C Gilkeson; Scot C Remick; Jose Ortiz
Myocardial stunning following combined modality combretastatin-based chemotherapy: two case reports and review of the literature.
Clinical cardiology 2009;32(12):E80-4.
2009: Rebecca Roth; Rebecca Newhouse; Beverly Robinson; Susan Faulkner; Scot C Remick
Bonnie's Bus--cancer disparities in West Virginia, philanthropy and opportunities to build lasting partnerships.
The West Virginia medical journal 2009;105 Spec No():68-72.
2009: Jame Abraham; James Keresztury; John Azar; Manish Monga; Timothy Bowers; Mathew Page Jones; Maria Tria Tirona; Jondavid Pollock; Craig Coonley; Steven Jubelirer; James Frame; Patti Fogg; Molly Getto; Shannon Filburn; John Naim; Dan Lucas; William Petros; Sharon Hall; Scot C Remick
Building a statewide clinical trials network for cancer care in West Virginia.
The West Virginia medical journal 2009;105 Spec No():6-11.
2009: Sharon L Sanborn; Joseph Gibbons; Smitha Krishnamurthi; Joanna M Brell; Afshin Dowlati; Joseph A Bokar; Charles Nock; Nancy Horvath; Jacob Bako; Scot C Remick; Matthew M Cooney
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
Investigational new drugs 2009;27(5):453-60.
2009: Walter O Mwanda; Jackson Orem; Pingfu Fu; Cecilia Banura; Joweria Kakembo; Caren Auma Onyango; Anne Ness; Sherrie Reynolds; John L Johnson; Vivek Subbiah; Jacob Bako; Henry Wabinga; Fatuma K Abdallah; Howard J Meyerson; Christopher Curtis Whalen; Michael M Lederman; Jodi Black; Leona W Ayers; Edward Katongole-Mbidde; Scot C Remick
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(21):3480-8.
2009: Joanna M Brell; Smitha S Krishnamurthi; Milind Javle; Joel Saltzman; Ira Wollner; Robert Pelley; Afshin Dowlati; Belagodu N Kantharaj; Mark D Schluchter; Linda Rath; S Percy Ivy; Scot C Remick
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
Cancer chemotherapy and pharmacology 2009;63(5):851-7.
2009: Colin J Mooney; Govardhanan Nagaiah; Pingfu Fu; Jay K Wasman; Matthew M Cooney; Panos S Savvides; Joseph A Bokar; Afshin Dowlati; Ding Wang; Sanjiv S Agarwala; Susan M Flick; Paul H Hartman; Jose D Ortiz; Pierre N Lavertu; Scot C Remick
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
Thyroid : official journal of the American Thyroid Association 2009;19(3):233-40.
2008: Sharon L Sanborn; Matthew M Cooney; Afshin Dowlati; Joanna M Brell; Smitha Krishnamurthi; Joseph Gibbons; Joseph A Bokar; Charles Nock; Anne Ness; Scot C Remick
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
Investigational new drugs 2008;26(4):355-62.
2008: Sakkaraiappan Ramalingam; Merrill J Egorin; Ramesh K Ramanathan; Scot C Remick; Rachel Sikorski; Theodore F Lagattuta; Gurkamal S Chatta; David M Friedland; Ronald G Stoller; Douglas M Potter; S Percy Ivy; Chandra P Belani
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3456-61.
2008: Afshin Dowlati; Sudhir Manda; Joseph Gibbons; Scot C Remick; Lauren Patrick; Pingfu Fu
Multi-institutional phase I trials of anticancer agents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1926-31.
2008: Joseph Gibbons; Merrill J Egorin; Ramesh K Ramanathan; Pingfu Fu; Daniel Mulkerin; Stephen Shibata; Chris H Takimoto; Sridhar Mani; Patricia M LoRusso; Jean L Grem; Anna Pavlick; Heinz-Josef Lenz; Susan M Flick; Sherrie Reynolds; Theodore F Lagattuta; Robert A Parise; Yanfeng Wang; Anthony J Murgo; S Percy Ivy; Scot C Remick
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):570-6.
2008: Ramesh K Ramanathan; Merrill J Egorin; Chris H Takimoto; Scot C Remick; James Doroshow; Patricia M LoRusso; Daniel Mulkerin; Jean L Grem; Anne Hamilton; Anthony J Murgo; Douglas M Potter; Chandra P Belani; Michael J Hayes; Bin Peng; S Percy Ivy
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):563-9.
2007: Beth Overmoyer; Pingfu Fu; Charles L Hoppel; Tomas Radivoyevitch; Robert Shenk; Marjie Persons; Paula Silverman; Kelly Robertson; Nicholas P Ziats; Jay K Wasman; Fadi W Abdul-Karim; John A Jesberger; Jeffrey Duerk; Paul Hartman; Shelli Hanks; JONATHAN LEWIN; Afshin Dowlati; Keith R McCrae; Percy Ivy; Scot C Remick
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5862-8.
2007: Willem J van Heeckeren; Sharon L Sanborn; Ajita Narayan; Matthew M Cooney; Keith R McCrae; Alvin H Schmaier; Scot C Remick
Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
Current opinion in hematology 2007;14(5):468-80.
2007: Chris H Takimoto; Martin A Graham; Graham Lockwood; Chee M Ng; Andrew Goetz; Dennis Greenslade; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; Timothy W Synold; James Doroshow; Anne Hamilton; Daniel Mulkerin; Percy Ivy; Merrill J Egorin; Jean L Grem
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4832-9.
2007: Eric D Batts; Christopher Maisel; Donna Kane; Lili Liu; Pingfu Fu; Timothy O'Brien; Scot C Remick; Nizar J Bahlis; Stanton L Gerson
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial.
Cancer chemotherapy and pharmacology 2007;60(3):415-21.
2007: Willem J van Heeckeren; Jose Ortiz; Matthew M Cooney; Scot C Remick
Hypertension, proteinuria, and antagonism of vascular endothelial growth factor signaling: clinical toxicity, therapeutic target, or novel biomarker?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):2993-5.
2007: Timothy W Synold; Chris H Takimoto; James Doroshow; David R Gandara; Sridhar Mani; Scot C Remick; Daniel Mulkerin; Anne Hamilton; Sunil Sharma; Ramesh K Ramanathan; Heinz-Josef Lenz; Martin Graham; Jeff Longmate; Bennett M Kaufman; Percy Ivy
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3660-6.
2006: Matthew M Cooney; Willem van Heeckeren; Shyam Bhakta; Jose Ortiz; Scot C Remick
Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery.
Nature clinical practice. Oncology 2006;3(12):682-92.
2006: Jackson Orem; Mwanda W Otieno; Scot C Remick
Challenges and opportunities for treatment and research of AIDS-related malignancies in Africa.
Current opinion in oncology 2006;18(5):479-86.
2006: John A Jesberger; Niusha Rafie; Jeffrey L Duerk; Jeffrey L Sunshine; Matthew Mendez; Scot C Remick; JONATHAN LEWIN
Model-free parameters from dynamic contrast-enhanced-MRI: sensitivity to EES volume fraction and bolus timing.
Journal of magnetic resonance imaging : JMRI 2006;24(3):586-94.
2006: Willem J van Heeckeren; Shyam Bhakta; Jose Ortiz; Jeff Duerk; Matthew M Cooney; Afshin Dowlati; Keith R McCrae; Scot C Remick
Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1485-8.
2005: Afshin Dowlati; Robert A Chapman; Shanmuga Subbiah; Pingfu Fu; Anne Ness; Tania Cortas; Lauren Patrick; Sherrie Reynolds; Natalie Xu; Nathan Levitan; Percy Ivy; Scot C Remick
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
Investigational new drugs 2005;23(6):563-7.
2005: Afshin Dowlati; Kelly Robertson; Tomas Radivoyevitch; John Waas; Nicholas P Ziats; Paul Hartman; Fadi W Abdul-Karim; Jay K Wasman; John A Jesberger; JONATHAN LEWIN; Keith R McCrae; Percy Ivy; Scot C Remick
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7938-44.
2005: Rosemary Rochford; Gerold Feuer; Jackson Orem; Cecily Banura; Edward Katongole-Mbidde; Walter O Mwanda; Ann M Moormann; William J Harrington; Scot C Remick
Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.
East African medical journal 2005;82(9 Suppl):S155-60.
2005: Jackson Orem; P Fu; Anne Ness; Walter O Mwanda; Scot C Remick
Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease.
East African medical journal 2005;82(9 Suppl):S144-9.
2005: Walter O Mwanda; Jackson Orem; Scot C Remick; Rosemary Rochford; Christopher Curtis Whalen; Mark Wilson
Clinical characteristics of Burkitt's lymphoma from three regions in Kenya.
East African medical journal 2005;82(9 Suppl):S135-43.
2005: Walter O Mwanda; Christopher Curtis Whalen; Scot C Remick
Burkitt's lymphoma and emerging therapeutic strategies for EBV and AIDS-associated lymphoproliferative diseases in East Africa.
East African medical journal 2005;82(9 Suppl):S133-4.
2005: Matthew M Cooney; Scot C Remick; Nicholas J Vogelzang
Promising systemic therapy for renal cell carcinoma.
Current treatment options in oncology 2005;6(5):357-65.
2005: Matthew M Cooney; Jose Ortiz; Ronald M Bukowski; Scot C Remick
Novel vascular targeting/disrupting agents: combretastatin A4 phosphate and related compounds.
Current oncology reports 2005;7(2):90-5.
2005: Matthew M Cooney; Kou-Yi Tserng; Vinit Makar; R Jeff McPeak; Stephen T Ingalls; Afshin Dowlati; Beth Overmoyer; Keith R McCrae; Pamela Ksenich; Pierre Lavertu; Percy Ivy; Charles L Hoppel; Scot C Remick
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.
Cancer chemotherapy and pharmacology 2005;55(3):295-300.
2005: Jackson Orem; Mwanda W Otieno; Cecily Banura; Edward Katongole-Mbidde; John L Johnson; Leona Ayers; Mahmoud Ghannoum; Pingfu Fu; Ellen G Feigal; Jodi Black; Christopher Curtis Whalen; Michael M Lederman; Scot C Remick
Capacity building for the clinical investigation of AIDS malignancy in East Africa.
Cancer detection and prevention 2005;29(2):133-45.
2005: OW Mwanda; P Fu; R Collea; Christopher Curtis Whalen; Scot C Remick
Kaposi's sarcoma in patients with and without human immunodeficiency virus infection, in a tertiary referral centre in Kenya.
Annals of tropical medicine and parasitology 2005;99(1):81-91.
2004: Cathy Eng; Ramesh K Ramanathan; Ramesh K Ramathan; Michael K Wong; Scot C Remick; Lanting Dai; Kurombi Wade-Oliver; Sridhar Mani; Hedy L Kindler
A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.
American journal of clinical oncology 2004;27(6):565-9.
2004: Matthew M Cooney; Scot C Remick; Nicholas J Vogelzang
Novel agents for the treatment of advanced kidney cancer.
Clinical advances in hematology & oncology : H&O 2004;2(10):664-70.
2004: Jackson Orem; Mwanda W Otieno; Scot C Remick
AIDS-associated cancer in developing nations.
Current opinion in oncology 2004;16(5):468-76.
2004: Matthew M Cooney; Scot C Remick; Nicholas J Vogelzang
A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?
Current urology reports 2004;5(1):19-24.
2004: Scot C Remick
Surrogate markers in oncology practice and anticancer drug development: lessons learned from antiretroviral therapy?
Cancer investigation 2004;22(1):164-8.
2004: Matthew M Cooney; Tomas Radivoyevitch; Afshin Dowlati; Beth Overmoyer; Nathan Levitan; Kelly Robertson; Sandra L Levine; Kathleen DeCaro; Carol Buchter; Anne Taylor; Bruce S Stambler; Scot C Remick
Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):96-100.
2003: Afshin Dowlati; Hillard M Lazarus; Paul Hartman; James Jacobberger; Cecilia M Whitacre; Stanton L Gerson; Pamela Ksenich; Brenda W Cooper; Phyllis S Frisa; Megan Gottlieb; Anthony J Murgo; Scot C Remick
Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed B-cell malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5929-35.
2003: Chris H Takimoto; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; James Doroshow; Anne Hamilton; Daniel Mulkerin; Martin Graham; Graham F Lockwood; Percy Ivy; Merrill J Egorin; Dennis Greenslade; Andrew Goetz; Jean L Grem
Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group.
Seminars in oncology 2003;30(4 Suppl 15):20-5.
2003: James Doroshow; Timothy W Synold; David R Gandara; Sridhar Mani; Scot C Remick; Daniel Mulkerin; Anne Hamilton; Sunil Sharma; Ramesh K Ramanathan; Heinz-Josef Lenz; Martin Graham; Jeff Longmate; Chris H Takimoto; Percy Ivy
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.
Seminars in oncology 2003;30(4 Suppl 15):14-9.
2003: Chris H Takimoto; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; James Doroshow; Anne Hamilton; Daniel Mulkerin; Martin Graham; Graham F Lockwood; Percy Ivy; Merrill J Egorin; Barbara Schuler; Dennis Greenslade; Andrew Goetz; Ronald Knight; Rebecca Thomas; Brian P Monahan; William Dahut; Jean L Grem
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2664-72.
2002: Afshin Dowlati; Kelly Robertson; Matthew M Cooney; William P Petros; Michael Stratford; John A Jesberger; Niusha Rafie; Beth Overmoyer; Vinit Makkar; Bruce S Stambler; Anne Taylor; John Waas; JONATHAN LEWIN; Keith R McCrae; Scot C Remick
A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.
Cancer research 2002;62(12):3408-16.
2002: Mwanda W Otieno; Cecily Banura; Edward Katongole-Mbidde; John L Johnson; Mahmoud Ghannoum; Afshin Dowlati; Rolf Renne; Eric Arts; Christopher Curtis Whalen; Michael M Lederman; Scot C Remick
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.
Journal of the National Cancer Institute 2002;94(10):718-32.
2001: Afshin Dowlati; John R Haaga; Scot C Remick; Timothy P Spiro; Stanton L Gerson; Lili Liu; Sosamma J Berger; Nathan A Berger; James Willson
Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):2971-6.
2001: J D Hillman; A T Peng; Anita Gilliam; Scot C Remick
Treatment of Kaposi sarcoma with oral administration of shark cartilage in a human herpesvirus 8-seropositive, human immunodeficiency virus-seronegative homosexual man.
Archives of dermatology 2001;137(9):1149-52.
2001: Mwanda W Otieno; Scot C Remick; Christopher Curtis Whalen
Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya.
International journal of cancer. Journal international du cancer 2001;92(5):687-91.
2001: Afshin Dowlati; L Crosby; Scot C Remick; Vinit Makkar; Nathan Levitan
Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):155-62.
2001: Afshin Dowlati; C L Hoppel; Stephen T Ingalls; Susan Majka; X Li; N Sedransk; T Spiro; Stanton L Gerson; Percy Ivy; Scot C Remick
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2309-18.
2001: Minakshi Nihal; Debra L Mikkola; Z Qian; Scot C Remick; Gary S Wood
The clonality of tumor-infiltrating lymphocytes in African Kaposi's sarcoma.
Journal of cutaneous pathology 2001;28(4):200-5.
2001: Scot C Remick; N Sedransk; R F Haase; C G Blanchard; C R Ramnes; T Nazeer; D M Mastrianni; B J Dezube
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up.
American journal of hematology 2001;66(3):178-88.
2001: Afshin Dowlati; Nathan Levitan; Nahida H Gordon; Charles L Hoppel; David Gosky; Scot C Remick; Stephen T Ingalls; Sosamma J Berger; Nathan A Berger
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 2001;47(2):141-8.
2000: Scot C Remick; M Patnaik; N M Ziran; KR Liegmann; J Dong; Afshin Dowlati; Y Yao; Fadi W Abdul-Karim; CZ Giam
Human herpesvirus-8-associated disseminated angiosarcoma in an HIV-seronegative woman: report of a case and limited case-control virologic study in vascular tumors.
The American journal of medicine 2000;108(8):660-4.
2000: Nathan Levitan; Afshin Dowlati; D Shina; M Craffey; Wilma Mackay; Russell F DeVore; J Jett; Scot C Remick; ALEX CHANG; D Johnson
Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1102-9.
1999: Afshin Dowlati; Nathan Levitan; Scot C Remick
Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancer.
The Journal of laboratory and clinical medicine 1999;134(4):405-9.
1999: Nathan Levitan; Afshin Dowlati; Scot C Remick; H I Tahsildar; LD Sivinski; Rebecca J Beyth; Alfred A Rimm
Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.
Medicine 1999;78(5):285-91.
1999: Scot C Remick; N Sedransk; R Haase; M Craffey; N Subramanian; Afshin Dowlati; T Nazeer; C Ramnes; C Blanchard; D Mastrianni; L Balducci; J Horton; John Ruckdeschel
Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies.
Drugs 1999;58 Suppl 3():99-107.
1998: Nathan Levitan; Afshin Dowlati; M Craffey; H Tahsildar; Wilma Mackay; J McKenney; Scot C Remick
A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
Lung cancer (Amsterdam, Netherlands) 1998;22(3):227-34.
1997: P Widrick; A Boguniewicz; T Nazeer; Scot C Remick
Breast cancer in a man with human immunodeficiency virus infection.
Mayo Clinic proceedings. Mayo Clinic 1997;72(8):761-4.
1996: R Vyzula; Scot C Remick
Lung cancer in patients with HIV-infection.
Lung cancer (Amsterdam, Netherlands) 1996;15(3):325-39.
1996: Scot C Remick
Non-AIDS-defining cancers.
Hematology/oncology clinics of North America 1996;10(5):1203-13.
1996: Scot C Remick
The spectrum of non-AIDS-defining neoplastic disease in HIV infection.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1996;44(5):205-15.
1996: Scot C Remick; M Chmura; C Bromberg; J Sporn; B Healey; J Hilstro; Ronald C DeConti; J Horton; John Ruckdeschel; G R Harper
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer.
American journal of clinical oncology 1996;19(2):125-31.
1996: Scot C Remick; M Reddy; K Ekman; R Vyzula; J Hilstro; J Horton
Continuous infusion etoposide in advanced AIDS-related kaposi sarcoma.
The Journal of infusional chemotherapy 1996;6(2):92-6.
1995: R J McCaffrey; J P Cousins; H J Westervelt; M Martynowicz; Scot C Remick; S Szebenyi; W A Wagle; Paul A Bottomley; C J Hardy; R F Haase
Practice effects with the NIMH AIDS abbreviated neuropsychological battery.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 1995;10(3):241-50.
1994: Scot C Remick; M Reddy; D Herman; C Grace; G Harper; K Willis; B Candon; J Horton; John Ruckdeschel
Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1130-6.
1993: David J Adelstein; L A Kalish; G L Adams; H Wagner; M M Oken; Scot C Remick; E G Mansour; R E Haselow
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2136-42.
1993: Scot C Remick; J J McSharry; B C Wolf; C G Blanchard; A Y Eastman; H Wagner; E Portuese; T Wighton; D Powell; T Pearce
Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(9):1691-702.
1993: Scot C Remick; A Boguniewicz; B Wolf
Solid tumors in HIV-infected patients other than AIDS-defining neoplasms.
Advances in experimental medicine and biology 1993;335():219-24.
1992: Scot C Remick; S A Hoisington; J A Migliozzi
Epidemic Kaposi's sarcoma presenting with pleuropericarditis.
New York state journal of medicine 1992;92(8):359-60.
1992: Scot C Remick; John Ruckdeschel
Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome.
Medical and pediatric oncology 1992;20(2):89-99.
1991: Scot C Remick; G R Harper; M A Abdullah; J J McSharry; J S Ross; John Ruckdeschel
Metastatic breast cancer in a young patient seropositive for human immunodeficiency virus.
Journal of the National Cancer Institute 1991;83(6):447-8.
1990: Scot C Remick; C Diamond; J A Migliozzi; O Solis; H Wagner; R F Haase; John Ruckdeschel
Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature.
Medicine 1990;69(6):345-60.